These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32279050)

  • 1. Synthesis of novel monocarbonyl curcuminoids, evaluation of their efficacy against MRSA, including ex vivo infection model and their mechanistic studies.
    Gagandeep ; Kumar P; Kandi SK; Mukhopadhyay K; Rawat DS
    Eur J Med Chem; 2020 Jun; 195():112276. PubMed ID: 32279050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of natural curcuminoids-intercalated layered double hydroxide nanohybrid against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis: A bactericidal, antibiofilm, and mechanistic study.
    Gayani B; Dilhari A; Wijesinghe GK; Kumarage S; Abayaweera G; Samarakoon SR; Perera IC; Kottegoda N; Weerasekera MM
    Microbiologyopen; 2019 May; 8(5):e00723. PubMed ID: 30221843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria.
    Sanabria-Ríos DJ; Rivera-Torres Y; Rosario J; Gutierrez R; Torres-García Y; Montano N; Ortíz-Soto G; Ríos-Olivares E; Rodríguez JW; Carballeira NM
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5067-71. PubMed ID: 26483137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
    Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of cell selective α/β-diastereomeric peptidomimetic with potent in vivo antibacterial activity against methicillin resistant S. Aureus.
    Dewangan RP; Bisht GS; Singh VP; Yar MS; Pasha S
    Bioorg Chem; 2018 Feb; 76():538-547. PubMed ID: 29310083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA).
    Aruldass CA; Masalamany SRL; Venil CK; Ahmad WA
    Environ Sci Pollut Res Int; 2018 Feb; 25(6):5164-5180. PubMed ID: 28361404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
    Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S
    Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of novel benzopolycyclic amines.
    Barniol-Xicota M; Escandell A; Valverde E; Julián E; Torrents E; Vázquez S
    Bioorg Med Chem; 2015 Jan; 23(2):290-6. PubMed ID: 25515953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
    Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
    J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA).
    Gatadi S; Gour J; Kaul G; Shukla M; Dasgupta A; Akunuri R; Tripathi R; Madhavi YV; Chopra S; Nanduri S
    Bioorg Chem; 2018 Dec; 81():175-183. PubMed ID: 30130650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
    Tellis M; Joseph J; Khande H; Bhagwat S; Patel M
    J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Bioactivities of New Membrane-Active Agents with Aromatic Linker: High Selectivity and Broad-Spectrum Antibacterial Activity.
    Chu W; Yang Y; Cai J; Kong H; Bai M; Fu X; Qin S; Zhang E
    ACS Infect Dis; 2019 Sep; 5(9):1535-1545. PubMed ID: 31328496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients.
    Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L
    J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodomyrtosone B, a membrane-targeting anti-MRSA natural acylgphloroglucinol from Rhodomyrtus tomentosa.
    Zhao LY; Liu HX; Wang L; Xu ZF; Tan HB; Qiu SX
    J Ethnopharmacol; 2019 Jan; 228():50-57. PubMed ID: 30195566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).
    Mohammad H; Reddy PV; Monteleone D; Mayhoub AS; Cushman M; Seleem MN
    Eur J Med Chem; 2015 Apr; 94():306-16. PubMed ID: 25771109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2008)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Feb; 68(1):19-36. PubMed ID: 25980051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).
    Guo Y; Xu T; Bao C; Liu Z; Fan J; Yang R; Qin S
    Eur J Pharm Sci; 2019 Aug; 136():104966. PubMed ID: 31233865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient Photodynamic Killing of Gram-Positive Bacteria by Synthetic Curcuminoids.
    Hung SJ; Hong YA; Lin KY; Hua YW; Kuo CJ; Hu A; Shih TL; Chen HP
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.